“Not a Straightforward Decision”: What to Do While Waiting on a Practice Change in Breast Cancer Care
In the wake of recent key data about ESR1-mutated metastatic breast cancer, treatment decisions have become more complicated. “In current clinical practice, this is not a straightforward decision,” Marla Lipsyc-Sharf, MD, explains to Robert A. Figlin, MD.
AI Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Oncology News Central Peer-Spectives
New Targeted Therapies Make Breast Cancer Treatment Decisions “a Bit of a Moving Target”
Advances in ESR1-Mutated Breast Cancer Care Lead to “Complex Situation” in Clinic
Tackling “the Biggest Question That Everyone Is Asking” in Breast Cancer Care
Shared Decision Making and Toxicity Management in EGFR- Mutated Advanced NSCLC
Get summaries like this every morning.
Free AI-powered recaps of Oncology News Central Peer-Spectives and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.